We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Plans envisaged by Mexican lawmakers to reform the country's cornerstone drug legislation, the General Health Law, have come under fire from industry groups.
Hungary's drugmakers and drug distributors have agreed to a deal with the government, paying compensation for budget overspends by the country's social insurance fund, OEP.
India's National Pharmaceutical Pricing Authority (NPPA) has announced price cuts of up to 36% on the prices of 16 drugs on the national essential medicines list.
Analysts are questioning whether Biovail Corp. will be the sole winner on the podium after the intense race by three small Canadian drugmakers to bring a revolutionary painkiller to the huge U.S. market.
Bausch & Lomb (NYSE:BOL) has completed the previously announced acquisition of a controlling interest in Shandong Chia Tai Freda Pharmaceutical Group (CTF), the leading ophthalmic pharmaceutical company in China, from Sino Biopharmaceutical Ltd.(HKSE: 1177.HK) for $200 million in cash.
BioLineRx, Israel's leading specialized drug development company, today announced that current investors Giza Venture Capital, Pitango Venture Capital and Teva Pharmaceuticals Industries Ltd. have committed an additional $9 million in funding to the company.
Solvay SA said it signed an agreement with Norway's Pronova Biocare giving Solvay Pharmaceuticals exclusive distribution rights for Pronova's Omacor in India, Pakistan, Sri Lanka, Thailand, Vietnam, Singapore, Malaysia, China, Hong-Kong and New Zealand.
South Africa's Enaleni Pharmaceuticals has agreed to buy Cipla Medpro for 1.2 billion rand and said on Monday it would apply to the stock exchange to join the bourse's main index.
South African hospital association HASA has defended rising private
healthcare costs, after a recent report showed that expenditure increased 18.5% in 2004.